IL148169A0 - Pharmaceutical compositions containing a benzamide derivative - Google Patents

Pharmaceutical compositions containing a benzamide derivative

Info

Publication number: IL148169A0
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; compositions containing; benzamide derivative; benzamide; derivative
Prior art date: 1999-08-16

Application number

IL14816900A

Other languages

English (en)

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-16

Filing date

2000-08-16

Publication date

2002-09-12

2000-08-16 Application filed by Schering Ag filed Critical Schering Ag

2002-09-12 Publication of IL148169A0 publication Critical patent/IL148169A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Dermatology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL14816900A 1999-08-16 2000-08-16 Pharmaceutical compositions containing a benzamide derivative IL148169A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP22955199A JP2001064177A (ja)	1999-08-16	1999-08-16	ベンズアミド誘導体を有効成分とする製剤
PCT/EP2000/008011 WO2001012193A1 (en)	1999-08-16	2000-08-16	Pharmaceutical agent comprising a benzamide derivative as active ingredient

Publications (1)

Publication Number	Publication Date
IL148169A0 true IL148169A0 (en)	2002-09-12

Family

ID=16893948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14816900A IL148169A0 (en)	1999-08-16	2000-08-16	Pharmaceutical compositions containing a benzamide derivative

Country Status (29)

Country	Link
EP (1)	EP1207881B1 (es)
JP (2)	JP2001064177A (es)
KR (1)	KR100683876B1 (es)
CN (1)	CN1205931C (es)
AR (1)	AR031074A1 (es)
AU (1)	AU780151B2 (es)
BG (1)	BG65662B1 (es)
BR (1)	BR0013283A (es)
CA (1)	CA2380757C (es)
CY (1)	CY1116273T1 (es)
CZ (1)	CZ302924B6 (es)
DK (1)	DK1207881T3 (es)
EE (1)	EE05331B1 (es)
ES (1)	ES2536705T3 (es)
HK (1)	HK1046501B (es)
HR (1)	HRP20020181B1 (es)
HU (1)	HU230386B1 (es)
IL (1)	IL148169A0 (es)
MX (1)	MXPA02001575A (es)
NO (1)	NO328957B1 (es)
NZ (1)	NZ517356A (es)
PL (1)	PL201388B1 (es)
PT (1)	PT1207881E (es)
RU (1)	RU2257206C2 (es)
SK (1)	SK287547B6 (es)
TW (1)	TWI245630B (es)
UA (1)	UA73316C2 (es)
WO (1)	WO2001012193A1 (es)
ZA (1)	ZA200201466B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001081031A (ja) *	1999-08-30	2001-03-27	Schering Ag	溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
US20040034039A1 (en) *	2000-09-22	2004-02-19	Yoshinori Nakano	Solid preparations
US7566535B2 (en)	2002-03-07	2009-07-28	University Of Delaware	Enhanced oligonucleotide-mediated nucleic acid sequence alteration
GB0316206D0 (en) *	2003-07-10	2003-08-13	Glaxo Group Ltd	Pharmaceutical formulation
WO2008123395A1 (ja)	2007-03-28	2008-10-16	Santen Pharmaceutical Co., Ltd.	ヒストン脱アセチル化酵素阻害作用を有する化合物を有効成分として含有する眼圧下降剤
KR101405615B1 (ko) *	2007-08-27	2014-06-12	(주)아모레퍼시픽	조성물 내 ｐＨ 조절을 통해 안정화된 벤즈아미드 화합물을함유하는 피부 외용제 조성물, 및 그 벤즈아미드 화합물안정화 방법
NZ591387A (en) *	2008-08-29	2012-03-30	Bayer Pharma AG	N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275) polymorph b
GB2462893B (en) *	2008-08-29	2010-10-13	Bayer Schering Pharma Ag	N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
KR102142257B1 (ko) *	2013-04-04	2020-08-07	다이이찌 산쿄 가부시키가이샤	아미노카르복실산의 염의 고형 조성물
CN107405322B (zh)	2015-03-19	2020-08-18	第一三共株式会社	含有抗氧化剂的固体制剂
JP6630344B2 (ja)	2015-03-19	2020-01-15	第一三共株式会社	着色剤を含有する固形製剤
KR102849723B1 (ko)	2018-07-30	2025-08-22	다이이찌 산쿄 가부시키가이샤	안정화제를 함유하는 의약품의 고형 제제
CN111867559A (zh) *	2019-01-25	2020-10-30	株式会社爱茉莉太平洋	含有苯甲酰胺化合物以及增溶剂的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU706415A1 (ru) *	1978-04-12	1979-12-30	Ташкентский Государственный Университет Им.В.И.Ленина	Итаконоил анабазин в качестве дыхательного аналептика
CZ284687B6 (cs) *	1986-04-30	1999-02-17	Dainippon Pharmaceutical Co., Ltd.	Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
JP3354090B2 (ja) *	1996-09-30	2002-12-09	シエーリングアクチエンゲゼルシャフト	分化誘導剤
US6174905B1 (en) *	1996-09-30	2001-01-16	Mitsui Chemicals, Inc.	Cell differentiation inducer

1999
- 1999-08-16 JP JP22955199A patent/JP2001064177A/ja active Pending
2000
- 2000-08-07 TW TW089115860A patent/TWI245630B/zh not_active IP Right Cessation
- 2000-08-15 AR ARP000104212A patent/AR031074A1/es active IP Right Grant
- 2000-08-16 CA CA002380757A patent/CA2380757C/en not_active Expired - Lifetime
- 2000-08-16 EP EP00951523.0A patent/EP1207881B1/en not_active Expired - Lifetime
- 2000-08-16 ES ES00951523.0T patent/ES2536705T3/es not_active Expired - Lifetime
- 2000-08-16 RU RU2002106815/15A patent/RU2257206C2/ru active
- 2000-08-16 HU HU0203226A patent/HU230386B1/hu unknown
- 2000-08-16 DK DK00951523.0T patent/DK1207881T3/da active
- 2000-08-16 CZ CZ20020540A patent/CZ302924B6/cs not_active IP Right Cessation
- 2000-08-16 MX MXPA02001575A patent/MXPA02001575A/es active IP Right Grant
- 2000-08-16 BR BR0013283-7A patent/BR0013283A/pt not_active Application Discontinuation
- 2000-08-16 HR HRP20020181AA patent/HRP20020181B1/hr not_active IP Right Cessation
- 2000-08-16 PT PT951523T patent/PT1207881E/pt unknown
- 2000-08-16 WO PCT/EP2000/008011 patent/WO2001012193A1/en not_active Ceased
- 2000-08-16 CN CNB008117187A patent/CN1205931C/zh not_active Expired - Lifetime
- 2000-08-16 IL IL14816900A patent/IL148169A0/xx active IP Right Grant
- 2000-08-16 UA UA2002032040A patent/UA73316C2/uk unknown
- 2000-08-16 PL PL353449A patent/PL201388B1/pl unknown
- 2000-08-16 NZ NZ517356A patent/NZ517356A/en not_active IP Right Cessation
- 2000-08-16 KR KR1020027002002A patent/KR100683876B1/ko not_active Expired - Lifetime
- 2000-08-16 HK HK02107641.6A patent/HK1046501B/zh not_active IP Right Cessation
- 2000-08-16 AU AU64427/00A patent/AU780151B2/en not_active Expired
- 2000-08-16 EE EEP200200073A patent/EE05331B1/xx unknown
- 2000-08-16 SK SK209-2002A patent/SK287547B6/sk not_active IP Right Cessation
- 2000-08-16 JP JP2001516539A patent/JP4854158B2/ja not_active Expired - Lifetime
2002
- 2002-02-15 NO NO20020774A patent/NO328957B1/no not_active IP Right Cessation
- 2002-02-21 ZA ZA200201466A patent/ZA200201466B/en unknown
- 2002-03-14 BG BG106516A patent/BG65662B1/bg unknown
2015
- 2015-05-13 CY CY20151100423T patent/CY1116273T1/el unknown

Also Published As

Publication number	Publication date
BG106516A (en)	2002-10-31
CN1205931C (zh)	2005-06-15
HUP0203226A2 (hu)	2003-01-28
EP1207881B1 (en)	2015-04-01
CA2380757C (en)	2009-01-27
KR100683876B1 (ko)	2007-02-15
CZ2002540A3 (cs)	2002-06-12
EP1207881A1 (en)	2002-05-29
EE200200073A (et)	2003-04-15
BR0013283A (pt)	2002-04-23
CN1370068A (zh)	2002-09-18
CA2380757A1 (en)	2001-02-22
ZA200201466B (en)	2002-09-02
NZ517356A (en)	2003-07-25
HRP20020181B1 (hr)	2016-01-29
UA73316C2 (uk)	2005-07-15
JP4854158B2 (ja)	2012-01-18
WO2001012193A1 (en)	2001-02-22
JP2003507330A (ja)	2003-02-25
HUP0203226A3 (en)	2003-12-29
AU6442700A (en)	2001-03-13
ES2536705T3 (es)	2015-05-27
NO20020774D0 (no)	2002-02-15
HK1046501B (zh)	2005-09-30
CZ302924B6 (cs)	2012-01-18
SK2092002A3 (en)	2002-07-02
HK1046501A1 (en)	2003-01-17
JP2001064177A (ja)	2001-03-13
PL353449A1 (en)	2003-11-17
EE05331B1 (et)	2010-08-16
NO328957B1 (no)	2010-06-28
PL201388B1 (pl)	2009-04-30
BG65662B1 (bg)	2009-05-29
KR20020020815A (ko)	2002-03-15
NO20020774L (no)	2002-03-04
RU2002106815A (ru)	2004-01-27
DK1207881T3 (da)	2015-06-22
HRP20020181A2 (en)	2005-10-31
MXPA02001575A (es)	2003-10-14
RU2257206C2 (ru)	2005-07-27
AR031074A1 (es)	2003-09-10
CY1116273T1 (el)	2017-02-08
HU230386B1 (hu)	2016-03-29
SK287547B6 (sk)	2011-01-04
AU780151B2 (en)	2005-03-03
PT1207881E (pt)	2015-06-05
TWI245630B (en)	2005-12-21

Publication	Publication Date	Title
IL148357A0 (en)	2002-09-12	Pharmaceutical compositions containing a benzamide derivative
IL149138A0 (en)	2002-11-10	Pharmaceutical compositions containing metformin
HUP0202513A3 (en)	2004-06-28	Betha-carboline pharmaceutical compositions
GB0001662D0 (en)	2000-03-15	Pharmaceutical compositions
GB0028088D0 (en)	2001-01-03	Pharmaceutical compositions
IL145177A0 (en)	2002-06-30	A pharmaceutical composition containing xenon
IL147778A0 (en)	2002-08-14	Pharmaceutical compositions containing cyclobenzaprine
PL351387A1 (en)	2003-04-07	Pharmaceutical composition
IL187526A0 (en)	2008-03-20	Pharmaceutical compositions containing an a?? fragment
GB9923436D0 (en)	1999-12-08	Pharmaceutical compositions
HUP0000137A3 (en)	2001-03-28	Controller-release pharmaceutical composition containing anangetics
EP1166786A4 (en)	2004-05-12	MEDICAL COMPOSITIONS
IL148169A0 (en)	2002-09-12	Pharmaceutical compositions containing a benzamide derivative
IL145632A0 (en)	2002-06-30	Pharmaceutical compounds
HUP0102894A3 (en)	2003-03-28	A substituted triazolo-pyridazine derivative, pharmaceutical compositions containing them
GB9904163D0 (en)	1999-04-14	Pharmaceutical compositions
IL148691A0 (en)	2002-09-12	Pharmaceutical compositions containing ciclesonide
GB9916434D0 (en)	1999-09-15	Pharmaceutical compounds
GB9911017D0 (en)	1999-07-14	Pharmaceutical compositions
IL148725A0 (en)	2002-09-12	Aqueous pharmaceutical compositions containing circlesonide
GB9914255D0 (en)	1999-08-18	Pharmaceutical compounds
GB9903784D0 (en)	1999-04-14	Pharmaceutical compounds
GB9904911D0 (en)	1999-04-28	Pharmaceutical compositions
IL122891A0 (en)	1998-08-16	Pharmaceutical compositions comprising a thiocarbamate
IL144285A0 (en)	2002-05-23	Pharmaceutical compositions containing a vasopeptidase inhibitor

Legal Events

Date	Code	Title
2008-07-09	FF	Patent granted
2008-11-03	KB	Patent renewed
2010-11-30	KB	Patent renewed
2014-07-31	KB	Patent renewed
2018-08-30	KB	Patent renewed